Home / Generics

Generics

News

Natco Pharma and Alvogen launch first US Tamiflu generic posted 20/01/2017

Natco Pharma (Natco) and their marketing partner Alvogen have launched the first generic equivalent of Roche’s flu treatment...

Mylan launches generic EpiPen posted 16/01/2017

US-based drugmaker Mylan announced on 16 December 2016 that it had launched the authorized generic version of its EpiPen (epi...

Lupin and Natco’s Armodafinil generic approved to treat sleep disorders by FDA posted 16/01/2017

The US subsidiary of Indian drug manufacturer, Lupin Pharmaceuticals, announced on 29 November 2016 that its Armodafinil tabl...

Mylan to make generic hepatitis drug under MPP sublicence posted 16/01/2017

Generics giant Mylan Pharmaceuticals (Mylan) announced on 28 November 2016 that the company had signed a sublicence with...

Dr Reddy’s makes deal with Gland Pharma for US injectables posted 18/11/2016

Generics manufacturer Dr Reddy’s Laboratories (Dr Reddy’s) announced on 26 October 2016 that it had entered into a ‘strategic...

 

Research

Addressing patient misconceptions about generics posted 02/12/2016

In the face of increasing drug costs, substitution by generics is often used as a strategy by healthcare systems to rein in e...

Policies to address price rises in old generics posted 25/11/2016

Old, off-patent drugs are becoming increasingly expensive. But how can policymakers address the problem? Naren P Tallapragada...

Therapeutic substitution could save Americans US$73 billion posted 18/11/2016

Therapeutic substitution could save the America healthcare system US$73 billion and patients US$24.6 billion in out-of-pocket...

Transparency in the Australian pharmaceutical industry posted 18/11/2016

In Australia, the promotion of medicines to healthcare professionals is controlled by self-regulatory schemes operated by the...

Factors affecting generics entry posted 18/11/2016

Edward Kong, Research Assistant at the Yale University, Department of Economics, carried out a study into the factors that in...

 

General

UK competition authority accuses Actavis of overcharging NHS posted 13/01/2017

The UK’s Competition and Markets Authority (CMA) has accused Actavis of breaching competition law by increasing the price of...

Competition does not curb high drug prices posted 10/01/2017

With increasing concern over price increases for medicines a new concern being raised is that increased competition in the ph...

FDA reports record number of generics approvals posted 02/12/2016

The US Food and Drug Administration’s (FDA) Office of Generic Drugs (OGD) latest activity report shows an increase in approva...

First prequalification submissions for generic dolutegravir posted 30/11/2016

The Medicines Patent Pool (MPP) announced on 10 November 2016 that two of its generics manufacturing partners are the first c...

Sandoz petitions FDA over requirements for generics of Advair Diskus posted 04/11/2016

Sandoz has asked the US Food and Drug Administration (FDA) not to approve generics of GlaxoSmithKline’s (GSK) chronic obstruc...